| Bioactivity | Nesuparib is a potent inhibitor of PARP. Nesuparib is useful for the research of neuropathic pain, neurodegenerative disease, and cardiovascular disease (extracted from patent WO2016200101A2)[1]. | ||||||||||||
| Target | PARP | ||||||||||||
| Name | Nesuparib | ||||||||||||
| CAS | 2055357-64-5 | ||||||||||||
| Formula | C23H24N6O | ||||||||||||
| Molar Mass | 400.48 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same. Patent WO2016200101A2. |
Nesuparib
CAS: 2055357-64-5 F: C23H24N6O W: 400.48
Nesuparib is a potent inhibitor of PARP. Nesuparib is useful for the research of neuropathic pain, neurodegenerative dis
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.